Loading
NASDAQFinancial ServicesShell Companies
Latest quote
$10.85
+$0.02 · +0.18%
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Latest quote
$10.85
+$0.02 · +0.18%
After-hours
$10.85
$0.00 · 0.00%
Oct 8, 4:00 PM ET
Regular session · ET · Market data may be delayed.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
52-week range
Current $10.85
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
48
Fair Value
Sentiment
56
Mixed
Risk
8
Low Risk
Momentum
40
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
52-week range
Current $10.85
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 |
|---|---|---|
| Selling, general, and administrative | 2.82M USD | 479.73 USD |
| Operating expenses | 2.82M USD | 479.73 USD |
| Interest income | 8.76M USD | — |
| Depreciation and amortization | — | 479.73K USD |
| Operating income | −2.82M USD | −479 USD |
| Net income | 5.94M USD | −479 USD |
Company facts updated Oct 8, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.